Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Belnoue, Elodie ^a   Fontannaz, Paola ^a   Rochat, Anne Françoise ^a   Tougne, Chantal ^a   Bergthaler, Andreas ^a   Lambert, Paul Henri ^a   Pinschewer, Daniel D ^a   Siegrist, Claire Anne ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ARENAVIRIDAE INFECTIONS; DENDRITIC CELLS; DNA PRIMERS; FLOW CYTOMETRY; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84893290244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085302     Document Type: Article

References (73)

1. Ohm-Smith MJ, Nassos PS, Haller BL (2004) Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus. J Clin Microbiol 42: 2996-2999 (Pubitemid 38938048)
2. Ruest A, Michaud S, Deslandes S, Frost EH (2003) Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 41: 3487-3493. doi:10.1128/JCM.41. 8.3487-3493.2003. PubMed: 12904343. (Pubitemid 36994671)
3. Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG et al. (2007) CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol 179: 8410-8417. PubMed: 18056387.
4. Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM et al. (2010) A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol 84: 2374-2383. doi:10.1128/JVI.01807-09. PubMed: 20015982.
5. Wilson CB, Penix L, Weaver WM, Melvin A, Lewis DB (1992) Ontogeny of T lymphocyte function in the neonate. Am J Reprod Immunol 28: 132-135. doi:10.1111/j.1600-0897.1992.tb00774.x. PubMed: 1285862. (Pubitemid 23044813)
6. Adkins B, Leclerc C, Marshall-Clarke S (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol 4: 553-564. doi:10.1038/nri1394. PubMed: 15229474. (Pubitemid 38931770)
7. Levy O (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390. doi:10.1038/nri2075.PubMed: 17457344.
8. Traub E (1936) An Epidemic in a Mouse Colony Due to the Virus of Acute Lymphocytic Choriomeningitis. J Exp Med 63: 533-546. doi:10.1084/jem.63.4.533. PubMed: 19870488.
9. Belnoue E, Fontannaz-Bozzotti P, Grillet S, Lambert PH, Siegrist CA (2007) Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J Virol 81: 7338-7350. doi: 10.1128/JVI.00062-07. PubMed: 17494081. (Pubitemid 47047823)
10. Bonjardim CA, Ferreira PC, Kroon EG (2009) Interferons: signaling, antiviral and viral evasion. Immunol Lett 122: 1-11. doi:10.1016/j.imlet. 2008.11.002. PubMed: 19059436.
11. Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B et al. (2007) Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol 178: 7540-7549. PubMed: 17548588. (Pubitemid 46898022)
12. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S et al. (2003) Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4: 1009-1015. doi:10.1038/nrg1251. PubMed: 14502286. (Pubitemid 37265922)
13. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207: 2053-2063. doi:10.1084/jem.20101664. PubMed: 20837696.
14. Havenar-Daughton C, Kolumam GA, Murali-Krishna K (2006) Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 176: 3315-3319. PubMed: 16517698. (Pubitemid 43363977)
15. Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S et al. (2012) Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A 109: 3012-3017. doi:10.1073/pnas.1117359109. PubMed: 22315415.
16. Welsh RM, Bahl K, Marshall HD, Urban SL (2012) Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog 8: e1002352. PubMed: 22241987.
17. Wiesel M, Kratky W, Oxenius A (2011) Type I IFN substitutes for T cell help during viral infections. J Immunol 186: 754-763. doi:10.4049/jimmunol. 1003166. PubMed: 21160039.
18. Oh S, Perera LP, Terabe M, Ni L, Waldmann TA et al. (2008) IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci U S A 105: 5201-5206. doi:10.1073/pnas.0801003105. PubMed: 18362335. (Pubitemid 351738534)
19. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ et al. (2005) CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93. doi:10.1038/nature03337. PubMed: 15744305. (Pubitemid 40349390)
20. Badovinac VP, Messingham KA, Griffith TS, Harty JT (2006) TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells. J Immunol 177: 999-1006. PubMed: 16818756. (Pubitemid 44036602)
21. Sun CM, Fiette L, Tanguy M, Leclerc C, Lo-Man R (2003) Ontogeny and innate properties of neonatal dendritic cells. Blood 102: 585-591. doi:10.1182/blood-2002-09-2966. PubMed: 12663436. (Pubitemid 36841979)
22. Dakic A, Shao QX, D'Amico A, O'Keeffe M, Chen WF et al. (2004) Development of the dendritic cell system during mouse ontogeny. J Immunol 172: 1018-1027. PubMed: 14707075. (Pubitemid 38113761)
23. Vollstedt S, O'Keeffe M, Ryf B, Glanzmann B, Hochrein H et al. (2006) The long-term but not the short-term antiviral effect of IFN-alpha depends on Flt3 ligand and pDC. Eur J Immunol 36: 1231-1240. doi:10.1002/eji.200535759. PubMed: 16639711.
24. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. doi:10.1126/science.8009221. PubMed: 8009221. (Pubitemid 24245635)
25. Wang Y, Swiecki M, Cella M, Alber G, Schreiber RD et al. (2012) Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral. Infection - Cell Host Microbe 11: 631-642. doi:10.1016/j.chom.2012.05.003.
26. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650. doi:10.1084/jem.20050821. PubMed: 16129706. (Pubitemid 41248415)
27. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N et al. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2: 1144-1150. doi:10.1038/ni736. PubMed: 11713464. (Pubitemid 33130149)
28. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C et al. (2002) Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195: 517-528. doi:10.1084/jem.20011672. PubMed: 11854364. (Pubitemid 34461304)
29. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606. doi:10.1038/nri2358. PubMed: 18641647.
30. Lee LN, Burke S, Montoya M, Borrow P (2009) Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice. J Immunol 182: 7178-7189. doi:10.4049/jimmunol.0802526. PubMed: 19454715.
31. Macal M, Lewis GM, Kunz S, Flavell R, Harker JA et al. (2012) Plasmacytoid Dendritic Cells Are Productively Infected and Activated through TLR-7 Early after Arenavirus. Infection - Cell Host Microbe 11: 617-630. doi:10.1016/j.chom.2012.04.017.
32. Honda K, Yanai H, Negishi H, Asagiri M, Sato M et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. doi:10.1038/nature03464. PubMed: 15800576. (Pubitemid 44739521)
33. Lande R, Gilliet M (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci 1183: 89-103. doi:10.1111/j.1749-6632.2009.05152.x. PubMed: 20146710.
34. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37-48. doi:10.1016/j.cell.2008.09.016. PubMed: 18854153.
35. Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B (2010) Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33: 905-916. doi:10.1016/j.immuni.2010. 11.023. PubMed: 21145760.
36. Rajagopal D, Paturel C, Morel Y, Uematsu S, Akira S et al. (2010) Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood 115: 1949-1957. doi:10.1182/blood-2009-08-238543. PubMed: 20065291.
37. Willems F, Vollstedt S, Suter M (2009) Phenotype and function of neonatal DC. Eur J Immunol 39: 26-35. doi:10.1002/eji.200838391. PubMed: 19137537.
38. Lukaszewski RA, Brooks TJ (2000) Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection. J Virol 74: 5006-5015. doi:10.1128/JVI.74.11.5006-5015.2000. PubMed: 10799574. (Pubitemid 30313839)
39. Basler CF, García-Sastre A (2002) Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol 21: 305-337. doi:10.1080/08830180213277. PubMed: 12486817.
40. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137. doi:10.1038/ni1303. PubMed: 16424890. (Pubitemid 43135878)
41. Lang PA, Cervantes-Barragan L, Verschoor A, Navarini AA, Recher M et al. (2009) Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 113: 1045-1052. PubMed: 18971424.
42. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5: 1249-1255. doi:10.1038/15200. PubMed: 10545990. (Pubitemid 29535601)
43. Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H et al. (2003) Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci U S A 100: 10872-10877. doi:10.1073/pnas.1934678100. PubMed: 12960379. (Pubitemid 37140120)
44. Cho HJ, Hayashi T, Datta SK, Takabayashi K, Van Uden JH et al. (2002) IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 168: 4907-4913. PubMed: 11994440. (Pubitemid 34495952)
45. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S et al. (2006) Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 176: 4682-4689. PubMed: 16585561.
46. Levey RH, Trainin N, Law LW, Black PH, Rowe WP (1963) Lymphocytic Choriomeningitis Infection in Neonataily Thymectomized Mice Bearing Diffusion Chambers Containing Thymus. Science 142: 481-485. doi:10.1126/science.142.3591. 481. PubMed: 17748162.
47. López CB, García-Sastre A, Williams BR, Moran TM (2003) Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187: 1126-1136. doi:10.1086/368381. PubMed: 12660927. (Pubitemid 36399354)
48. Vollstedt S, Franchini M, Hefti HP, Odermatt B, O'Keeffe M et al. (2003) Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med 197: 575-584. doi:10.1084/jem.20021900. PubMed: 12615899. (Pubitemid 36314653)
49. Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW (2012) Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection. J Virol 86: 11254-11265. doi:10.1128/JVI. 00576-12. PubMed: 22875973.
50. Ou R, Zhou S, Huang L, Moskophidis D (2001) Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol 75: 8407-8423. doi:10.1128/JVI.75.18.8407-8423.2001. PubMed: 11507186. (Pubitemid 32768945)
51. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA et al. (2010) Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 84: 9452-9462. doi:10.1128/JVI.00155-10. PubMed: 20592086.
52. Montoya M, Edwards MJ, Reid DM, Borrow P (2005) Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN. J Immunol 174: 1851-1861. PubMed: 15699111. (Pubitemid 40223924)
53. Jung A, Kato H, Kumagai Y, Kumar H, Kawai T et al. (2008) Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J Virol 82: 196-206. doi:10.1128/JVI.01640- 07. PubMed: 17942529. (Pubitemid 350309136)
54. Cervantes-Barragan L, Züst R, Weber F, Spiegel M, Lang KS et al. (2007) Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137. PubMed: 16985170. (Pubitemid 46220660)
55. Vollstedt S, O'Keeffe M, Odermatt B, Beat R, Glanzmann B et al. (2004) Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFNalpha production. Eur J Immunol 34: 1849-1860. doi:10.1002/eji.200324443. PubMed: 15214033. (Pubitemid 39256067)
56. Reizis B (2010) Regulation of plasmacytoid dendritic cell development. Curr Opin Immunol 22: 206-211. doi:10.1016/j.coi.2010.01.005. PubMed: 20144853.
57. Nagasawa M, Schmidlin H, Hazekamp MG, Schotte R, Blom B (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur J Immunol 38: 2389-2400. doi:10.1002/eji.200838470. PubMed: 18792017.
58. Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C et al. (2007) Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 204: 1107-1118. doi:10.1084/jem.20062013. PubMed: 17485512. (Pubitemid 46798154)
59. Lund JM, Linehan MM, Iijima N, Iwasaki A (2006) Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 177: 7510-7514. PubMed: 17114418. (Pubitemid 44846264)
60. Smit JJ, Rudd BD, Lukacs NW (2006) Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203: 1153-1159. doi:10.1084/jem.20052359. PubMed: 16682497. (Pubitemid 43736586)
61. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M (2010) Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955-966. doi:10.1016/j.immuni.2010.11.020. PubMed: 21130004.
62. Olitsky PK, Sabin AB, Cox HR (1936) An Acquired Resistance of Growing Animals to Certain Neurotropic Viruses in the Absence of Humoral Antibodies or Previous Exposure to Infection. J Exp Med 64: 723-737. doi:10.1084/jem.64.5.723. PubMed: 19870564.
63. Lines JL, Hoskins S, Hollifield M, Cauley LS, Garvy BA (2010) The migration of T cells in response to influenza virus is altered in neonatal mice. J Immunol 185: 2980-2988. doi:10.4049/jimmunol.0903075. PubMed: 20656925.
64. Fernandez MA, Evans IA, Hassan EH, Carbone FR, Jones CA (2008) Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo. Eur J Immunol 38: 102-113. doi:10.1002/eji.200636945. PubMed: 18081035.
65. Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M et al. (2008) A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4: e29. doi:10.1371/journal.ppat.0040029. PubMed: 18282093.
66. De Wit D, Tonon S, Olislagers V, Goriely S, Boutriaux M et al. (2003) Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 21: 277-281. doi:10.1016/j.jaut.2003.08.003. PubMed: 14599853. (Pubitemid 37410116)
67. Danis B, George TC, Goriely S, Dutta B, Renneson J et al. (2008) Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur J Immunol 38: 507-517. doi:10.1002/eji. 200737760. PubMed: 18200500.
68. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F et al. (2010) Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLOS ONE 5: e10407. doi:10.1371/journal.pone.0010407. PubMed: 20442853.
69. Gold MC, Donnelly E, Cook MS, Leclair CM, Lewinsohn DA (2006) Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr Res 60: 34-37. doi:10.1203/01.pdr.0000220352. 13547.f4. PubMed: 16690948. (Pubitemid 44297609)
70. Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A et al. (2012) Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol 276: 114-121. doi:10.1016/j.cellimm.2012.04.010. PubMed: 22578600.
71. Upham JW, Zhang G, Rate A, Yerkovich ST, Kusel M, et al. (2009) Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing. J Allergy Clin Immunol 124: 707-713 e702
72. Zhang X, Lepelley A, Azria E, Lebon P, Roguet G et al. (2013) Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLOS ONE 8: e52003. doi:10.1371/journal. pone.0052003. PubMed: 23326320.
73. Banchereau J, Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392. doi:10.1016/j.immuni.2006.08.010. PubMed: 16979570. (Pubitemid 44354221)